监管与产业动态· FierceBiotech·· 9 天前评分30
Vaxcyte肺炎球菌疫苗对标辉瑞、默沙东表现不输，公司股价应声上涨
Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer's, Merck’s shots - Fierce Biotech
导读
Vaxcyte肺炎球菌疫苗在与辉瑞、默沙东同类产品的对比中表现不输，公司股价应声上涨。投资者将这一表现视为Vaxcyte在肺炎球菌疫苗赛道中具备竞争潜力的正面信号。
来源：监管与产业动态 · news.google.com